No results were found for the filter!
ODN 1668 (Type B) Endotoxin-free (sterile) Item number: IAX-200-001-M001
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1720 (Cat. No.: IAX-200-200).
| Keywords: | CpG ODN TLR9 Agonist: B Type (species: rodent) |
| Application: | TLR9 activator |
| MW: | 6383 D |
From 119.00€ *
ODN 1826 (Type B) Endotoxin-free (sterile) Item number: IAX-200-002-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1982 (Cat. No.: IAX-200-201).
| Keywords: | CpG ODN TLR9 Agonist: B Type (species: rodent) |
| Application: | TLR9 activator |
| Reactivity: | Mouse, Rat |
| MW: | 6383 D |
From 119.00€ *
ODN 1585 (Type A) Endotoxin-free (sterile) Item number: IAX-200-003-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2218 (Cat. No.: IAX-200-203). Unmethylated CG dinucleotides within particular sequence contexts are responsible for the...
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: rodent) |
| Application: | TLR9 activator |
| MW: | 6643 D |
From 119.00€ *
ODN M362 (Type C) Endotoxin-free (sterile) Item number: IAX-200-004-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 6644 D |
From 119.00€ *
ODN 2216 (Type A) Endotoxin-free (sterile) Item number: IAX-200-005-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 6644 D |
From 119.00€ *
ODN 2006 (Type B) Endotoxin-free (sterile) Item number: IAX-200-006-M001
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2137 (Cat. No.: IAX-200-206).
| Keywords: | CpG ODN TLR9 Agonist: B Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 7720 D |
From 119.00€ *
iODN (inhibitory ODN) 2088 Endotoxin-free (sterile) Item number: IAX-200-050-M001
Potent sequence of an inhibitory ODN for in vivo use in rodents (50-150 µg per injection): prototype class I, may also affect TLR7 and TLR8 signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 4887 D |
From 94.00€ *
iODN (inhibitory ODN) (ttaggg)4 Endotoxin-free (sterile) Item number: IAX-200-051-M001
Potent sequence of an inhibitory ODN for in vivo use in rodents (100-300 µg per injection), prototype class II, inhibits STAT signaling, independent of TLR signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class II |
| Application: | STAT signaling inhibitor |
| MW: | 8288 D |
From 94.00€ *
G-type iODN (inhibitory ODN) Endotoxin-free (sterile) Item number: IAX-200-052-M001
Potent sequence of an inhibitory ODN of the poly-G class I targeting TLR9, but without effect on TLR7 and TLR8 signaling, for in vivo use in rodents (50-150 µg per injection). Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 6735 D |
From 94.00€ *
Mini-iODN (inhibitory ODN) Endotoxin-free (sterile) Item number: IAX-200-053-M001
Potent sequence of an inhibitory ODN for in vivo use in rodents (50-150 µg per injection): prototype class I, may also affect TLR7 and TLR8 signaling. egative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 3584 D |
From 94.00€ *
Mega-iODN (inhibitory ODN) Endotoxin-free (sterile) Item number: IAX-200-054-M001
Particularly potent sequence of an inhibitory ODN for in vivo use in rodents (50-150µg per injection): based on class I (ODN H154) and class II (ODN A151) sequences to combine inhibitory activity on TLRs and STAT signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I/II |
| Application: | TLR9 competitor |
| MW: | 5894 D |
From 94.00€ *
Duo-iODN (inhibitory ODN) Endotoxin-free (sterile) Item number: IAX-200-055-M001
Potent sequence of an inhibitory ODN for in vivo use in rodents (50-150µg per injection): prototype class I that also inhibits TLR7 signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 5867 D |
From 94.00€ *
Viewed